191 related articles for article (PubMed ID: 9855014)
1. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver.
Peters JM; Aoyama T; Cattley RC; Nobumitsu U; Hashimoto T; Gonzalez FJ
Carcinogenesis; 1998 Nov; 19(11):1989-94. PubMed ID: 9855014
[TBL] [Abstract][Full Text] [Related]
2. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
4. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
Woods CG; Burns AM; Bradford BU; Ross PK; Kosyk O; Swenberg JA; Cunningham ML; Rusyn I
Toxicol Sci; 2007 Aug; 98(2):366-74. PubMed ID: 17483499
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
Yeldandi AV; Rao MS; Reddy JK
Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
[TBL] [Abstract][Full Text] [Related]
6. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
Woods CG; Kosyk O; Bradford BU; Ross PK; Burns AM; Cunningham ML; Qu P; Ibrahim JG; Rusyn I
Toxicol Appl Pharmacol; 2007 Dec; 225(3):267-77. PubMed ID: 17950772
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
Peters JM; Rusyn I; Rose ML; Gonzalez FJ; Thurman RG
Carcinogenesis; 2000 Apr; 21(4):823-6. PubMed ID: 10753222
[TBL] [Abstract][Full Text] [Related]
9. Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation.
Kiss A; Ortiz-Aguayo R; Sharp R; Merlino G; Thorgeirsson SS; Gonzalez FJ; Peters JM
Carcinogenesis; 2001 Jun; 22(6):975-9. PubMed ID: 11375907
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators.
Anderson SP; Cattley RC; Corton JC
Mol Carcinog; 1999 Dec; 26(4):226-38. PubMed ID: 10569800
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
[TBL] [Abstract][Full Text] [Related]
12. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
[TBL] [Abstract][Full Text] [Related]
15. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
Gonzalez FJ; Shah YM
Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
[TBL] [Abstract][Full Text] [Related]
16. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA
Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472
[TBL] [Abstract][Full Text] [Related]
17. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
Cherkaoui-Malki M; Meyer K; Cao WQ; Latruffe N; Yeldandi AV; Rao MS; Bradfield CA; Reddy JK
Gene Expr; 2001; 9(6):291-304. PubMed ID: 11764000
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice.
Yang Q; Xie Y; Alexson SE; Nelson BD; DePierre JW
Biochem Pharmacol; 2002 May; 63(10):1893-900. PubMed ID: 12034374
[TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
